Accumulation of NACP/α-synuclein in Lewy body disease and multiple system atrophy

Journal of Neurology Neurosurgery and Psychiatry

Volumn 68, Issue 5, 2000, Pages 605-608

  Shoji, Mikio ^a   Tomidokoro, Yasushi ^a   Shizuka, Masami ^a   Amari, Masakuni ^d   Kosaka, Kenji ^e   Nakazato, Yoichi ^a   Okamoto, Koichi ^a   Hirai, Shunsaku ^f   Harigaya, Yasuo ^a   Sasaki, Atsushi ^a   Uéda, Kenji ^b   Ishiguro, Koji ^c   Matsubara, Etsuro ^a   Watanabe, Mitsunori ^a   Ikeda, Masaki ^a   Kanai, Mitsuyasu ^a  

^a GUNMA UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^c MAEBASHI RED CROSS HOSPITAL   (Japan)

^d Geriatrics Research Institute and Hospital   (Japan)

^e YOKOHAMA CITY UNIVERSITY   (Japan)

^f TOKYO METROPOLITAN NEUROLOGICAL HOSPITAL   (Japan)

Author keywords

Multiple system atrophy; NACP; Parkinson's disease; synuclein

Indexed keywords

ALPHA SYNUCLEIN; GENE PRODUCT;

ADULT; AGED; ARTICLE; ASTROCYTE; BASAL GANGLION; BRAIN CORTEX; BRAIN STEM; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; INFERIOR OLIVE; LEWY BODY; MAJOR CLINICAL STUDY; NERVE CELL; OLIGODENDROGLIA; PARKINSON DISEASE; PRIORITY JOURNAL; SHY DRAGER SYNDROME; SPINAL CORD; WHITE MATTER;

EID: 20244375969     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.68.5.605     Document Type: Article

References (23)

1. Parkinson J. An essay on the shaking palsy. In: Critcheley M, eds. James Parkinson, London: Macmillan, 1955.
2. Levy FH. Paralysis agitans 1. Pathologisch Anatomie. In: Lewandowski M, eds. Handbuch der Neurologie III. Berlin: Springer Verlag 1912:920-33.
3. Trétiakoff MC. Contribution a l'étude de l'anatomie pathologique de Locus Niger de Soemmerling [thesis]. Paris: Université de Paris, 1919.
4. Uéda K, Fukushima H, Masliah E, et al. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc Natl Acad Sci USA 1993;90:11282-6.
5. Jakes R, Spillantini MG, Goedert M. Identification of two distinct synucleins from human brain. FEBS Lett 1994; 345:27-32.
6. Iwai A, Masliah E, Yoshimoto M, et al. The precursor protein of non-A β component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron 1995;14:467-75.
7. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 1997;276:2045-7.
8. Krüger R, Kuhn W, Muller T, et al. Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease. Nat Genet 1998;18:106-8.
9. Yoshimura M. Cortical changes in the parkinsonian brain: a contribution to the delineation of "diffuse Lewy body disease". J Neurol 1983;229:17-32.
10. Kosaka K, Yoshimura M, Ikeda K, et al. Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree. A new disease? Clin Neuropathol 1984;3:185-92.
11. Graham J, Oppenheimer D. Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy. J Neurol Neurosurg Psychiatry 1969;32:28-34.
12. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113-24.
13. Ishimaru H, Ueda K, Takahashi A, et al. Changes in presynaptic protein NACP/α-synuclein in an ischemic gerbil hippocampus. Brain Res 1998;788:311-4.
14. Spillantini MG, Schmidt ML, Lee VM, et al. α-synuclein in Lewy bodies. Nature 1997;388:839-40.
15. Baba M, Nakajo S, Tu PH, et al. Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol 1998;152:879-84.
16. Takeda A, Mallory M, Sundsmo M, et al. Abnormal accumulation of NACP/α-synuclein in neurodegenerative disorders. Am J Pathol 1998;152:367-72.
17. Nakazato Y, Yamazaki H, Hirato J, et al. Oligodendroglial microtubular tangles in olivopontocerebellar atrophy. J Neuropathol Exp Neurol 1990;49:521-30.
18. Papp MI, Lantos PL. Accumulation of tubular structures in oligodendroglial and neuronal cells as the basic alteration in multiple system atrophy. J Neurol Sci 1992;107:172-82.
19. Mezey E, Dehejia A, Harta G, et al. α Synuclein in neurodegenerative disorders: murderer or accomplice? Nat Med 1998;4:755-7
20. Tu PH, Galvin JE, Baba M, et al. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α-synuclein. Ann Neurol 1998;44:415-22
21. Masliah E, Iwai A, Mallory M, et al. Altered presynaptic protein NACP is associated with plaque formation and neurodegeneration in Alzheimer's disease. Am J Pathol 1996;148:201-10.
22. Yoshimoto M, Iwai A, Kang D, et al. NACP, the precursor protein of the non-amyloid β/A4 protein (A β) component of Alzheimer disease amyloid, binds A β and stimulates A β aggregation. Proc Natl Acad Sci U S A 1995;92:9141-5.
23. Hardy J, Gwinn-Hardy K. Genetic classification of primary neurodegenerative disease. Science 1998;282:1075-9.